Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects. PLOS ONE, 2024 by Evelyn Ma | Aug 25, 2024
Development of Potent Mcl‑1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen by Andrew Khouri | Feb 15, 2024
PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates by Andrew Khouri | Feb 15, 2024
Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. Bioorganic & Medicinal Chemistry Letters, 2014 by Reaction Biology | Nov 20, 2023
Thiophene-pyrazolourea derivatives as potent, orally bioavailable, and isoform-selective jnk3 inhibitors. ACS Medicinal Chemistry Letters, 2021 by Reaction Biology | Nov 20, 2023